EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proliferation-associated protein 2G4 promotes keratinocyte proliferation and survival in psoriasis

Theresa Raunegger iD, Sophia Wasserer iD, Jessica Eigemann iD, Christina Hillig iD, Görkem Aydin iD, Nils Kurzen iD, Carsten B Schmidt-Weber iD, Michael P Menden iD, Natalie Garzorz-Stark iD, Inga Weßels iD, Stefanie Eyerich iD, Kilian Eyerich iD und 3 weitere

British Journal of Dermatology · 2026

DOI: 10.1093/bjd/ljag154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2026. Verfasst von Theresa Raunegger und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Psoriasis, Keratinocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psoriasis is a noncommunicable inflammatory skin disease that affects approximately 2–3% of the world’s population. Given its high impact on quality of life and the fact that a subset of patients exhibits suboptimal or secondary loss of response to current treatments, identifying new therapeutic strategies is crucial. Proliferation-associated protein 2G4 (PA2G4) is a transcription factor that has been exclusively studied in cancer research, where it promotes cell growth and enhances tumorigenesis by inhibiting apoptosis. However, its role in inflammatory skin diseases remains largely unknown.

Objectives

To elucidate the pathophysiological and immunological functions of PA2G4 in psoriasis, and to evaluate its potential as a therapeutic target.

Methods

Bulk, single-cell and spatial RNA sequencing (RNAseq) combined with immunohistochemistry were used to assess PA2G4 expression in psoriatic skin compared with nonlesional control samples. Functional studies were performed in primary human keratinocytes and reconstructed human epidermis (RHE) models using the CRISPR/Cas9-mediated knockout of PA2G4 and pharmacological inhibition of PA2G4 with the small-molecule inhibitor WS6. The regulatory effects of PA2G4 on cellular processes, such as proliferation, differentiation and survival, were investigated using RNAseq, Western blot analysis, scratch assays and annexin V staining.

Results

PA2G4 was highly abundant in psoriasis, and its expression was predominantly restricted to basal proliferating keratinocytes. Its expression was positively correlated with psoriasis severity, the degree of acanthosis, neutrophil infiltration and genes that are upregulated in psoriasis. PA2G4 knockout in primary human keratinocytes activated differentiation pathways while suppressing proliferation pathways, resulting in the downregulation of proliferation- and inflammation-related genes (e.g. MKI67, IL20, VEGFA and HIF1A) and the upregulation of differentiation and cell adhesion markers (e.g. KRT6C, LCE2C and DSG4). Functionally, PA2G4 knockout reduced keratinocyte proliferation in scratch assays, attenuated interleukin-22-induced acanthosis in RHE models and promoted keratinocyte death. Pharmacological inhibition of PA2G4 using the small-molecule inhibitor WS6 similarly downregulated genes associated with proliferation and cell survival.

Conclusions

PA2G4 could promote keratinocyte hyperproliferation and survival in psoriasis, thereby critically influencing epidermal homeostasis. Therefore, inhibition of PA2G4 may represent a new treatment option for psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisKeratinocytesHumansCell ProliferationCell SurvivalCells, CulturedApoptosisCell DifferentiationMale

Autor:innen und Institutionen

  • Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
  • ZAUM - Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.
  • Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.
  • Department of Computational Health, Institute of Computational Biology, Helmholtz Munich, Neuherberg, Germany.
  • Department of Mathematics, Technical University of Munich, Munich, Germany.
  • German Center of Lung Research (DZL), Neuherberg, Germany.

ORCID-Profile: Theresa Raunegger, Sophia Wasserer, Jessica Eigemann, Christina Hillig, Görkem Aydin, Nils Kurzen, Carsten B Schmidt-Weber, Michael P Menden, Natalie Garzorz-Stark, Inga Weßels, Stefanie Eyerich, Kilian Eyerich, Tilo Biedermann, Felix Lauffer, Manja Jargosch

Zitieren

APA

Raunegger, T., Wasserer, S., Eigemann, J., Hillig, C., Aydin, G., Kurzen, N., Schmidt-Weber, C. B., Menden, M. P., Garzorz-Stark, N., Weßels, I., Eyerich, S., Eyerich, K., Biedermann, T., Lauffer, F., & Jargosch, M. (2026). Proliferation-associated protein 2G4 promotes keratinocyte proliferation and survival in psoriasis. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljag154

Vancouver

Raunegger T, Wasserer S, Eigemann J, Hillig C, Aydin G, Kurzen N, et al. Proliferation-associated protein 2G4 promotes keratinocyte proliferation and survival in psoriasis. British Journal of Dermatology. 2026. doi:10.1093/bjd/ljag154

BibTeX
@article{Raunegger2026,
  author = {Raunegger, Theresa and Wasserer, Sophia and Eigemann, Jessica and Hillig, Christina and Aydin, Görkem and Kurzen, Nils and Schmidt-Weber, Carsten B and Menden, Michael P and Garzorz-Stark, Natalie and Weßels, Inga and Eyerich, Stefanie and Eyerich, Kilian and Biedermann, Tilo and Lauffer, Felix and Jargosch, Manja},
  title = {Proliferation-associated protein 2G4 promotes keratinocyte proliferation and survival in psoriasis},
  journal = {British Journal of Dermatology},
  year = {2026},
  doi = {10.1093/bjd/ljag154}
}
Kostenlos starten →